Resonance Health Ltd has released a press release.
Maylasian NAFLD - Diabetes Study
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Resonance Health
- Results Recommending Use of FerriScan in Sickle Cell Disease
- Resonance Health commences involvement in diabetes study
- Bone Marrow Iron - Regulatory Submission
- Expansion of Involvement in Pharmaceutical Clinical Trial
- HepaFat-Scan International Scientific Journal
Later from Resonance Health
- Half year report
- Cancer Survivor Campaign Update
- Evidence Building for HepaFat-Scan
- Quarterly Report
- Artificial Intelligence Solution for Emerging Markets
Follow Resonance Health into a list and get an email when it puts out news.
Follow Resonance Health